Feifel David, Melendez Gilia, Priebe Kristianne, Shilling Paul D
Department of Psychiatry, University of California, San Diego, La Jolla, CA, United States.
Behav Brain Res. 2007 Aug 6;181(2):278-86. doi: 10.1016/j.bbr.2007.04.020. Epub 2007 May 1.
We previously reported that vasopressin deficient Brattleboro (BRAT) rats exhibit deficits in prepulse inhibition (PPI) of the startle reflex that are consistent with PPI deficits exhibited by patients with schizophrenia and other neuropsychiatric disorders. Preliminary evidence indicates that this may be the basis of a predictive model for antipsychotic drug efficacy. Here we report the effects of acute and chronic administration of established and putative antipsychotics on these PPI deficits. BRAT rats, compared to their derivative strain, Long Evans rats, exhibited significantly decreased PPI and startle habituation consistent with patients with schizophrenia and other neuropsychiatric disorders. The second generation antipsychotics, risperidone and clozapine as well as a neurotensin agonist (PD149163) increased BRAT rat PPI, whereas saline, the typical antipsychotic, haloperidol, and a vasopressin analog (1-desamino-D-arginine vasopressin) did not. Similar to their effects in humans, chronic administration of antipsychotic drugs produced stronger effects than acute administration. These results further support the BRAT rat as a model of sensorimotor gating deficits with predictive validity for antipsychotics. The model appears to be able to differentiate first generation from second generation antipsychotics, identify putative antipsychotics with novel mechanisms (i.e., peptides) and reasonably model the therapeutic time course of antipsychotic drugs in humans.
我们之前报道过,血管加压素缺乏的Brattleboro(BRAT)大鼠在惊吓反射的前脉冲抑制(PPI)方面存在缺陷,这与精神分裂症和其他神经精神疾病患者表现出的PPI缺陷一致。初步证据表明,这可能是抗精神病药物疗效预测模型的基础。在此,我们报告已确立的和假定的抗精神病药物急性和慢性给药对这些PPI缺陷的影响。与它们的衍生品系Long Evans大鼠相比,BRAT大鼠表现出明显降低的PPI和惊吓习惯化,这与精神分裂症和其他神经精神疾病患者一致。第二代抗精神病药物利培酮和氯氮平以及一种神经降压素激动剂(PD149163)增加了BRAT大鼠的PPI,而生理盐水、典型抗精神病药物氟哌啶醇和一种血管加压素类似物(1-去氨基-D-精氨酸血管加压素)则没有。与它们在人类中的作用相似,抗精神病药物的慢性给药产生的效果比急性给药更强。这些结果进一步支持BRAT大鼠作为感觉运动门控缺陷模型,对抗精神病药物具有预测效度。该模型似乎能够区分第一代和第二代抗精神病药物,识别具有新机制(即肽类)的假定抗精神病药物,并合理模拟抗精神病药物在人类中的治疗时间进程。